S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|InterMune To Release Fourth Quarter Financial Results On February 21 (2013/2/11)|
|InterMune To Release First Quarter Financial Results On April 24 (2013/4/17)|
|Esbriet® (pirfenidone) Receives Positive Final Appraisal Determination from NICE for Idiopathic Pulmonary Fibrosis (IPF) (2013/3/20)|
|InterMune Reports Fourth Quarter And Full Year 2012 Financial Results And Business Highlights (2013/2/21)|
|InterMune Reports First Quarter 2013 Financial Results and Business Highlights (2013/4/24)|
|U.S. Food and Drug Administration Approved 30% More Drugs in 2012 (2013/2/22)|
|Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013 (2013/2/4)|
|Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013 (2013/1/29)|
|Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer (2013/3/21)|
|Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop (2013/4/4)|
Click above to view more mutual fund data and stats for itmn - InterMune, Inc..